CSIMarket
 
Biora Therapeutics Inc   (NASDAQ: BIOR)
 

Biora Therapeutics Inc's Suppliers Performance

BIOR's Supply Chain




 
BIOR Costs vs Sales of Suppliers Growth

More on BIOR Suppliers






Biora Therapeutics Inc's Comment on Supply Chain


The text outlines quality assurance procedures in manufacturing, including supplier and contractor selection, complaint handling, and documentation. It details compliance with FDA regulations covering labeling, unique device identification, advertising, promotion, sale restrictions, premarket approval (PMA) reporting, medical device reporting, correction and removal reporting, recall requirements, device tracking, and post-market surveillance. Manufacturers are required to maintain device master files, device history files, and complaint files, and are subject to FDA inspections. Non-compliance may result in manufacturing shutdowns, product recalls, warning letters, injunctions, bans, seizures, and legal actions. Additionally, manufacturers must comply with applicable state, local, and foreign government requirements following marketing approvals.

Biora Therapeutics Inc's Comment on Supply Chain


The text outlines quality assurance procedures in manufacturing, including supplier and contractor selection, complaint handling, and documentation. It details compliance with FDA regulations covering labeling, unique device identification, advertising, promotion, sale restrictions, premarket approval (PMA) reporting, medical device reporting, correction and removal reporting, recall requirements, device tracking, and post-market surveillance. Manufacturers are required to maintain device master files, device history files, and complaint files, and are subject to FDA inspections. Non-compliance may result in manufacturing shutdowns, product recalls, warning letters, injunctions, bans, seizures, and legal actions. Additionally, manufacturers must comply with applicable state, local, and foreign government requirements following marketing approvals.







BIOR's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Biora Therapeutics Inc 0.80 0.20 -31.54 17
SUBTOTAL 0.00 0.00 0.00 -


Sources: Biora Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Biora Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.